Reliance Chemotex Industries Limited — Important, 12-02-2025: Financial Result Updates

**Financial Summary for Reliance Chemotex Industries Ltd.**

Consolidated financials for the quarter and nine months ended December 31, 2024, show total revenue from operations at ₹9,223 million, reflecting a quarter-over-quarter growth of approximately 0.7%. This modest increase could be attributed to stable demand and slight operational improvements, though further analysis is required to identify specific market dynamics influencing this growth.

Net profit for the period stands at ₹220 million, compared to ₹143 million in the same quarter last year, indicating a year-over-year increase of 54%. The earnings per share (EPS) for the period is ₹2.92, up from ₹1.89 a year ago, reflecting improved profitability driven by efficient cost management strategies and working capital management.

Operational costs have increased slightly, with the cost of raw materials consumed rising to ₹4,753 million, a 2% increase from the previous quarter. However, other expenses are being monitored closely to ensure ongoing efficiency.

The balance sheet remains robust with total equity at ₹12,609 million. The cash flow statement indicates healthy liquidity, allowing for further investment in business expansion or strategic initiatives.

Strategically, the company appears focused on maintaining cost control while cautiously expanding its operational footprint. Market sentiment is optimistic, reflecting the company’s solid recovery and positioning for future growth.

Investors might consider a **buy** strategy due to the company’s strong profitability trend, prudent cost management, and potential for further operational enhancements.